|
|
|
|
Friday, July 28, 2006
By LAWRENCE HAJNA
Courier-Post Staff
Federal health officials on Thursday released a report
that concludes the Army's controversial plan to discharge wastewater from the
destruction of a deadly nerve agent into the Delaware River is safe.
But the report has done nothing to quell passionate
opposition to the plan.
Two South Jersey congressmen vowed the project will go
nowhere until the independent investigative arm of Congress, the Government
Accountability Office, reviews it.
Rep. Rob Andrews, D-Haddon Heights, and Rep. Frank A.
LoBiondo, R-Ventnor, conducted a telephone news conference to discuss the
findings by the Centers for Disease Control and Prevention. For the second
time, the CDC assessed the plan that calls for DuPont in Carneys Point to treat
wastewater from the destruction of VX nerve agent at an Army depot in Indiana.
The CDC found that DuPont has adequately addressed
ecological issues related to the discharge of the caustic wastewater into the
river and determined the project posed no other health, environmental or
transportation problems.
Andrews and LoBiondo said they believe the CDC's
evaluation was not thorough enough and have asked for a complete GAO review of
alternatives.
A measure they sponsored in a Defense Department
authorization bill going through Congress delays the plan until at least
February 2007.
"There is no chance that the project will begin
before that review, in large part because the state Department of Environmental
Protection will not grant a permit at this time," LoBiondo said.
"This is so very serious, residents are scared
out of their wits," he added.
Asked whether he would support the plan should the GAO
find no problems, Andrews said, "I'm so convinced, based on my own
analysis, I can't imagine that they would come back and say that."
Jeff Lindblad, spokesman for the Army's Chemical
Materials Agency, acknowledged the plan must still clear these hurdles and some
technical points raised in the CDC study. But he viewed the CDC report as an
important step toward getting the project, on hold since early 2004, on track.
"It shows the EPA and CDC have independently
verified that our proposal is safe for the workers, the public and the
environment," he said.
In a statement, Nick Fanandakis, vice president and
general manager for DuPont Chemical Solutions Enterprise, said he was pleased
with the CDC's findings.
"From the outset, we said we would be involved in
this proposal only if it can be accomplished safely and effectively without any
adverse impact on the community, our employees or the environment," he
said.
The Army has destroyed more than 250 tons of its
1,200-ton VX stockpile at the Newport Chemical Deport in west-central Indiana.
It is storing the wastewater on site until it can begin shipping the material
to DuPont, which does not yet have a contract.
While the Army insists the hydrolysate -- a caustic
wastewater produced by the destruction of the nerve agent -- will contain no
detectable VX, Andrews said he "remains unalterably opposed" because
of the Army's track record of spills at Newport and the dangers even a drop of
VX can pose to human life.
"The DuPont proposal has met with fierce
opposition from all quarters and that opposition continues to expand,"
said Tracy Carluccio of the Delaware Riverkeeper Network, an environmental
group. "The people and their elected representatives will fight the Army's
plan to truck VX nerve agent waste and discharge it to the Delaware
River."
Reach
Lawrence Hajna at (856) 486-2466 or lhajna@courierpostonline.com